Ignelzi Troy A.
SEC-identified person · CIK 1579829 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Contineum Therapeutics, Inc. CTNM | Director | filed 2024 - 2026 |
| Harmony Biosciences Holdings, Inc. HRMY | Director | filed 2026 - 2026 |
| Rapport Therapeutics, Inc. RAPP | Chief Financial Officer | filed 2024 - 2026 |
| Karuna Therapeutics, Inc. KRTX | Chief Financial Officer | filed 2019 - 2023 |
| Cincor Pharma, Inc. CINC | Director | filed 2022 - 2023 |
| Scpharmaceuticals Inc. SCPH | Chief Financial Officer | filed 2017 - 2018 |
| Esperion Therapeutics, Inc. ESPR | Vice President | filed 2013 - 2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.